Multiple studies have demonstrated correlation between PSMA expression and prostate cancer aggressiveness (5), Gleason score (6), metastatic potential (7) and castration resistance (8, 9), suggesting that PSMA is a promising imaging/therapeutic target. The gene discussed is FOLH1; the disease is prostate carcinoma.